Back to Search Start Over

Incidence of second primary malignancy (SPM) in melphalan-prednisone-lenalidomide combination followed by lenalidomide maintenance (MPR-R) in newly diagnosed multiple myeloma patients (pts) age 65 or older

Authors :
Palumbo, AP Delforge, Michel Catalano, J Hajek, R Kropff, M Petrucci, MT Yu, Z Mei, JM Dimopoulos, MA
Publication Year :
2011

Subjects

Subjects :
Health Sciences
Επιστήμες Υγείας

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..1762fd8082b613986c039f42184571ad

Tools

Authors Abstract Subjects Details